Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon 4 mg in Adults with Chronic Insomnia
2007-000403-15Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Insomnia and Sleep onset insomnia comparing Ramelteon 4 mg with Placebo (2 arms). Primary endpoint: Latency to persistent sleep (LPS) via polysomnography over Nights 1 and 2. Started May 2007; status: completed.
02
Drugs
ramelteon
03
Conditions
InsomniaSleep onset insomnia
Beyond the preview
Go deeper on 2007-000403-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000403-15.